中华病理学杂志
中華病理學雜誌
중화병이학잡지
Chinese Journal of Pathology
2009年
5期
329-332
,共4页
齐茸杰%张培红%邱录贵%方立环%杨晴英%孙福军%陈辉树
齊茸傑%張培紅%邱錄貴%方立環%楊晴英%孫福軍%陳輝樹
제용걸%장배홍%구록귀%방립배%양청영%손복군%진휘수
白血病%淋巴瘤%慢性%骨髓检查%预后
白血病%淋巴瘤%慢性%骨髓檢查%預後
백혈병%림파류%만성%골수검사%예후
Leukemia%lymphocytic%chronic%Bone marrow examination%Prognosis
目的 探讨慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)病理学特点及ZAP-70蛋白表达的预后意义.方法 采用免疫组织化学EliVision法,回顾性检测ZAP-70在52例CLL/SLL患者淋巴结和骨髓活检组织中的表达特点,并随访患者.结果 (1)病理学特征:12例淋巴结呈现均一性成熟小淋巴细胞增生,6例可见增殖中心.40例骨髓中瘤细胞形态与淋巴结的相似,但未见增殖中心.浸润模式分为结节型(9例)、间质型(3例)、混合型(9例)、弥漫型(19例)4种,比较非弥漫型和弥漫型存活率,二者差异无统计学意义(Fisher精确检验,P=0.199).(2)ZAP-70表达定位在细胞质和细胞核,21例(40.4%)患者ZAP-70阳性,其中因本病或感染等相关因素死亡11例.31例(59.6%)ZAP-70阴性,包括因本病或感染死亡4例.比较二组生存期,阳性组明显较阴性组短(39个月和59个月,x2=6.991,P=0.008).(3)随访51例患者,死亡21例,其中因本病及感染等相关因素死亡15例.结论 CLL/SLL患者ZAP-70阳性表达提示预后不良.
目的 探討慢性淋巴細胞白血病/小淋巴細胞淋巴瘤(CLL/SLL)病理學特點及ZAP-70蛋白錶達的預後意義.方法 採用免疫組織化學EliVision法,迴顧性檢測ZAP-70在52例CLL/SLL患者淋巴結和骨髓活檢組織中的錶達特點,併隨訪患者.結果 (1)病理學特徵:12例淋巴結呈現均一性成熟小淋巴細胞增生,6例可見增殖中心.40例骨髓中瘤細胞形態與淋巴結的相似,但未見增殖中心.浸潤模式分為結節型(9例)、間質型(3例)、混閤型(9例)、瀰漫型(19例)4種,比較非瀰漫型和瀰漫型存活率,二者差異無統計學意義(Fisher精確檢驗,P=0.199).(2)ZAP-70錶達定位在細胞質和細胞覈,21例(40.4%)患者ZAP-70暘性,其中因本病或感染等相關因素死亡11例.31例(59.6%)ZAP-70陰性,包括因本病或感染死亡4例.比較二組生存期,暘性組明顯較陰性組短(39箇月和59箇月,x2=6.991,P=0.008).(3)隨訪51例患者,死亡21例,其中因本病及感染等相關因素死亡15例.結論 CLL/SLL患者ZAP-70暘性錶達提示預後不良.
목적 탐토만성림파세포백혈병/소림파세포림파류(CLL/SLL)병이학특점급ZAP-70단백표체적예후의의.방법 채용면역조직화학EliVision법,회고성검측ZAP-70재52례CLL/SLL환자림파결화골수활검조직중적표체특점,병수방환자.결과 (1)병이학특정:12례림파결정현균일성성숙소림파세포증생,6례가견증식중심.40례골수중류세포형태여림파결적상사,단미견증식중심.침윤모식분위결절형(9례)、간질형(3례)、혼합형(9례)、미만형(19례)4충,비교비미만형화미만형존활솔,이자차이무통계학의의(Fisher정학검험,P=0.199).(2)ZAP-70표체정위재세포질화세포핵,21례(40.4%)환자ZAP-70양성,기중인본병혹감염등상관인소사망11례.31례(59.6%)ZAP-70음성,포괄인본병혹감염사망4례.비교이조생존기,양성조명현교음성조단(39개월화59개월,x2=6.991,P=0.008).(3)수방51례환자,사망21례,기중인본병급감염등상관인소사망15례.결론 CLL/SLL환자ZAP-70양성표체제시예후불량.
Objective To study the clinicopathologic features and prognostic significance of ZAP-70 protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Methods The histologic features of 52 cases of CLL/SLL with lymph node and/or bone marrow biopsies performed were retrospectively reviewed, lmmunohistochemical study using EliVision for ZAP-70 protein was adopted.Results The lymph nodes of the 12 cases studied showed effacement of the nodal architecture and was replaced by a monotonous infiltration of small lymphoid cells. Among them, proliferation centers were identified in 6 cases. Similar morphologic pattern was seen in the 40 bone marrow biopsy samples, but no proliferation center formation obtained. The infiltration pattern of tumor cells in the bone marrow were further subdivided into nodular (n=9), interstitial(n=3), mixed (n=9) and diffuse types (n=19). There was no significant difference found on survival rates between the diffuse infiltration and non-diffuse infiltration groups (Fisher's exact test, P=0. 199). ZAP-70 protein was mainly located in the cytoplasm and nuclei of lymphoma cells. There were 21 cases (40.4%) positive for ZAP-70 and among them, 11 died of this disease or the related infections. On the other hand, ZAP-70 was negative in 31 cases (59. 6% ) and only 4 of them died of this disease or related infections. The overall survival in ZAP-70-negative group was higher than that of the ZAP-70-positive group (59 months versus 39 months, X2=6. 991, P=0. 008). Follow-up information was available in 51 patients. Among the 21 dead cases, 15 died of CLL/SLL or the related infection. Conclusion A positive expression of ZAP-70 protein in CLL/SLL suggests a poor prognosis.